What is the total value of India's pharmaceutical export to Vietnam?

India exported pharmaceuticals worth $1.8M to Vietnam across 40 verified shipments.

Who are the top Indian pharmaceutical exporters to Vietnam?

1. BIOPLA FZ LLC,. B17-310, RAK CUSTOM BLDG — $1.2M. 2. BIOPLA FZ LLC, — $475.3K. 3. UNI- PRESIDENT VIETNAM CO., LTD — $73.1K. Total: 20 suppliers.

Which companies in Vietnam import pharmaceuticals from India?

1. SANUM SANGUINEAS SOLUTIONS PRIVATE LIMITED — $1.7M. 2. ARUN PRAWN SUPPLIERS — $58.8K. 3. PV ENTERPRISES — $47.8K. 16 buyers total.

What pharmaceutical products does India export most to Vietnam?

1. Plasma ($1.7M, 93.0%); 2. Probiotics ($126.0K, 6.8%); 3. Calcium ($842, 0.0%); 4. Vitamin ($842, 0.0%); 5. Vaccine ($400, 0.0%)

Why does Vietnam import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $1.8M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Vietnam?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Vietnam pharmaceutical trade?

$46.1K per consignment across 40 shipments.

How many Indian pharmaceutical companies export to Vietnam?

20 Indian companies. Largest: BIOPLA FZ LLC,. B17-310, RAK CUSTOM BLDG with $1.2M.

How can I find verified Indian pharmaceutical suppliers for Vietnam?

TransData Nexus covers 20 active exporters with shipment history and trade values at transdatanexus.com.

Vietnam to India Pharmaceutical Import (2026) — $1.8M, 20 Foreign Suppliers | TransData Nexus

Vietnam to India Pharmaceutical Import (2026) — $1.8M, 20 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Vietnam to India

#	Formulation	Value	Share
1	Plasma	$1.7M	93.0%
2	Probiotics	$126.0K	6.8%
3	Calcium	$842	0.0%
4	Vitamin	$842	0.0%
5	Vaccine	$400	0.0%
6	Azithromycin	$151	0.0%
7	Empagliflozin	$115	0.0%
8	Metformin	$110	0.0%
9	Rosuvastatin	$63	0.0%
10	Immunoglobulin	$24	0.0%
11	Ibuprofen	$10	0.0%

India imports 11+ pharmaceutical formulations from Vietnam with a combined trade value of $1.8M. Key products include Plasma ($1.7M), Probiotics ($126K), Calcium ($842), Vitamin ($842), Vaccine ($400). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 40 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Vietnam to India Trade Routes

1Plasma$1.7M

2Probiotics$126K

3Calcium$842

4Vitamin$842

5Vaccine$400

6Azithromycin

Top Vietnam Suppliers to India

1Biopla Fz Llc,. B17-310, Rak Custom Bldg

$1.2M

2Biopla Fz Llc,

$475K

3Uni- President Vietnam Co., Ltd

$73K

4Uni- President Vietnam Co. Limited

$27K

5Uni-president Vietnam Co., Ltd

$15K

Trade Statistics

Total Value$1.8M

Shipments40

Indian Exporters20

Vietnam Buyers16

Avg Shipment$46K

Products11

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Vietnam Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Vietnam and India has experienced significant growth over the past decade. In 2022, bilateral trade reached a historic high of nearly $15 billion, marking a 13.92% increase from the previous year. Vietnam's exports to India amounted to $7.96 billion, while imports stood at $7.08 billion. This upward trajectory continued into 2025, with trade reaching nearly $16.46 billion, a 10.5% year-on-year increase. (en.vietnamplus.vn)

The pharmaceutical sector has been a key contributor to this growth. In 2023, Vietnam's pharmaceutical exports to India were valued at $1.17 million, according to the United Nations COMTRADE database. This figure reflects the strengthening trade relations and the increasing integration of Vietnam into India's pharmaceutical supply chain.

2Vietnam's Role in India's Pharma Imports

Vietnam's share in India's pharmaceutical imports remains modest but is growing steadily. In 2023, Vietnam's pharmaceutical exports to India were valued at $1.17 million, according to the United Nations COMTRADE database. This positions Vietnam as a niche supplier in India's diverse pharmaceutical import portfolio. The primary categories of pharmaceutical products imported from Vietnam include plasma, probiotics, and various vitamins and minerals. These products cater to specific therapeutic needs and complement India's domestic pharmaceutical offerings.

Vietnam Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

For Vietnamese pharmaceutical companies aiming to export finished pharmaceutical formulations to India, obtaining approval from the Central Drugs Standard Control Organisation (CDSCO) is mandatory. The registration process involves submitting a comprehensive dossier that includes detailed information about the drug, its manufacturing process, and clinical trial data. Form 40 is typically used for the registration of new drugs, while Form 41 is used for the registration of new drugs for clinical trials. In certain cases, the CDSCO may grant clinical trial waivers if the drug has been approved in other countries with stringent regulatory standards. The timeline for registration can vary, but it generally takes several months to complete the process.

2GMP & Manufacturing Standards

India requires that all pharmaceutical products imported into the country comply with Good Manufacturing Practice (GMP) standards. Vietnamese manufacturing sites must adhere to these standards to ensure product quality and safety. The World Health Organization (WHO) prequalification is often recognized as evidence of compliance with GMP standards. The CDSCO conducts inspections of manufacturing facilities to verify adherence to these standards. Manufacturers must provide detailed information about their facilities, processes, and quality control measures as part of the registration process.

3Import Documentation

Importing pharmaceutical products into India requires several key documents:

Import License (Form 10): Issued by the Directorate General of Foreign Trade (DGFT), this license authorizes the import of specific pharmaceutical products.

Registration Certificate: Issued by the CDSCO, this certificate confirms that the pharmaceutical product has been approved for sale in India.

No Objection Certificate (NOC): Obtained from the Ministry of Health and Family Welfare, this certificate indicates that the product does not pose a risk to public health.

Test License: Required for the importation of drugs for testing purposes, this license is issued by the CDSCO.

Additionally, importers must comply with customs procedures, including the payment of applicable duties and taxes, and ensure that the products meet India's quality standards.

===BLOCK===

IMPORT_TRENDS

TransData Nexus Research · Vietnam regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Vietnam

Dominant categories, emerging opportunities, and demand drivers

1Dominant Import Categories

India's pharmaceutical imports from Vietnam are predominantly composed of specific therapeutic products. The top three products imported include plasma, probiotics, and various vitamins and minerals. Plasma products, accounting for 93.0% of the total import value, are essential for treating a range of medical conditions. Probiotics, comprising 6.8% of the imports, are increasingly recognized for their role in digestive health and immune support. Vitamins and minerals, though representing a smaller fraction, are vital for addressing nutritional deficiencies prevalent in certain populations.

2Innovation & Specialty Imports

Vietnam's pharmaceutical exports to India include several innovative and specialty products not widely manufactured domestically. For instance, plasma products are critical for treating various medical conditions and are sourced from Vietnam to meet specific therapeutic needs. Probiotics and certain vitamins and minerals are also imported to address gaps in India's domestic production and to offer specialized formulations that cater to diverse patient requirements.

3Import Demand Drivers

The demand for pharmaceutical imports from Vietnam to India is driven by several factors:

Patent Protection: Imported drugs may be protected under patents, allowing for exclusive marketing rights and the introduction of novel therapies.

Technology Gaps: Vietnamese manufacturers may offer advanced formulations and technologies not yet available in India, fulfilling unmet medical needs.

Quality Requirements: Imported products may adhere to international quality standards, providing assurance of safety and efficacy.

Disease Burden: Specific health challenges in India may necessitate the importation of specialized pharmaceutical products to effectively address these issues.

===BLOCK===

IMPORT_POLICY

TransData Nexus Research · DGFT trade data analysisMar 2026

Trade Policy & Tariff Intelligence — India and Vietnam

Tariff structure, trade agreements, IP and patent landscape

1India's Import Tariff Structure

India's import tariff structure for pharmaceutical formulations includes several components:

Most Favored Nation (MFN) Tariff Rates: These rates are applied to imports from countries with which India has trade agreements, ensuring non-discriminatory treatment.

Basic Customs Duty (BCD): A standard duty imposed on imported goods, including pharmaceuticals.

Integrated Goods and Services Tax (IGST): A tax levied on the import of goods, which is creditable against output tax liabilities.

Health Cess: An additional levy on imported medical devices and equipment, intended to fund health initiatives.

These tariffs and taxes are subject to change based on India's fiscal policies and trade agreements.

2Trade Agreements & Preferences

India and Vietnam have engaged in various trade agreements to enhance bilateral trade, including the Regional Comprehensive Economic Partnership (RCEP). These agreements aim to reduce tariffs and non-tariff barriers, providing preferential duty rates for member countries. Such agreements facilitate smoother trade flows and encourage the importation of pharmaceutical products from Vietnam to India.

3IP, Patents & Price Control

India's patent regime, particularly Section 3(d) of the Indian Patents Act, allows for the rejection of patents on new forms of known substances unless they demonstrate enhanced efficacy. This provision aims to prevent evergreening of patents and promote generic competition. The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of essential drugs, including imported pharmaceuticals, to ensure affordability. Compulsory licensing provisions enable the government to grant licenses to produce patented drugs without the consent of the patent holder, particularly in cases of public health emergencies.

===BLOCK===

IMPORT_LOGISTICS

TransData Nexus Research · Trade policy databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Vietnam identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 40 verified shipments from 20 Indian exporters to 16 Vietnam buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

20 Exporters

16 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Vietnam to India Pharmaceutical Import

Top Pharmaceutical Formulations — Vietnam to India

Top Pharmaceutical Products — Vietnam to India Trade Routes

Top Vietnam Suppliers to India

Trade Statistics

Other Import Origins

India–Vietnam Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Vietnam's Role in India's Pharma Imports

Top Indian Buyers from Vietnam

Product Routes

Full Dataset Access

3Recent Developments

Vietnam Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Vietnam

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Vietnam

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Vietnam Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

FAQ — India to Vietnam Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Vietnam?

Who are the top Indian pharmaceutical exporters to Vietnam?

Which companies in Vietnam import pharmaceuticals from India?

What pharmaceutical products does India export most to Vietnam?

Which ports handle pharmaceutical shipments from India to Vietnam?

Why does Vietnam import pharmaceuticals from India?

What certifications do Indian pharmaceutical exporters need to supply Vietnam?

What is the average shipment value for India to Vietnam pharmaceutical trade?

How many Indian pharmaceutical companies export to Vietnam?

How can I find verified Indian pharmaceutical suppliers for Vietnam?

Unlock the Full India to Vietnam Pharmaceutical Export Dataset

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology